Feb 17, 2026 09:15AM
Jan 29, 2026 07:05AM
Dec 30, 2025 06:36AM
Dec 29, 2025 07:05AM
Dec 8, 2025 07:32AM
Dec 1, 2025 01:41PM
Nov 12, 2025 08:36AM Unicycive Therapeutics (UNCY) PT Lowered to $63 at Lucid Capital Markets
Nov 12, 2025 08:10AM
Nov 3, 2025 09:10AM
Oct 29, 2025 06:49AM
Oct 28, 2025 07:06AM
Oct 15, 2025 08:59AM
Sep 15, 2025 08:57AM
Aug 18, 2025 07:05AM Unicycive receives patent for kidney disease drug UNI-494
Aug 14, 2025 04:11PM
Jul 24, 2025 08:02AM
Jul 8, 2025 08:31AM
Jul 1, 2025 09:34AM
Jun 30, 2025 07:05AM
Jun 30, 2025 07:01AM
Jun 17, 2025 07:01AM Unicycive Therapeutics, Inc (UNCY) Announces 1:10 Reverse Share Split
Jun 11, 2025 06:38AM
Jun 10, 2025 06:02AM
Jun 4, 2025 06:19AM
May 21, 2025 08:48AM
May 14, 2025 04:59PM
Apr 11, 2025 06:38AM
Apr 10, 2025 09:14AM Benchmark Reiterates Speculative Buy Rating on Unicycive Therapeutics (UNCY)
Apr 1, 2025 06:46AM
Feb 20, 2025 07:02AM
Jan 28, 2025 07:02AM
Jan 7, 2025 07:01AM
Nov 13, 2024 05:05PM
Nov 12, 2024 07:52AM
Nov 11, 2024 07:01AM Unicycive Therapeutics (UNCY) Announces U.S. FDA Acceptance of the NDA for Oxylanthanum Carbonate
Oct 14, 2024 07:04AM
Oct 10, 2024 06:58AM
Oct 9, 2024 07:04AM
Sep 7, 2024 08:00PM
Sep 6, 2024 06:52AM
Sep 4, 2024 07:27AM
Sep 3, 2024 07:03AM Unicycive Therapeutics (UNCY) Announces Submission of NDA to U.S. FDA for Oxylanthanum Carbonate for Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Aug 16, 2024 06:44AM
Aug 14, 2024 04:02PM
Jul 17, 2024 07:03AM
Jul 11, 2024 10:32AM
Jul 10, 2024 02:03PM
Jul 10, 2024 07:03AM
Jun 25, 2024 07:33AM Unicycive Therapeutics (UNCY) Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All